LENZ Therapeutics, Inc. - LENZ
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | — | A | A | 22,100.0 | 0.0 | 0.0 | 22,100.0 | View | |
| Jun 15, 2026 | — | A | A | 22,100.0 | 0.0 | 0.0 | 22,100.0 | View | |
| Jun 15, 2026 | — | A | A | 22,100.0 | 0.0 | 0.0 | 22,100.0 | View | |
| Jun 15, 2026 | — | A | A | 22,100.0 | 0.0 | 0.0 | 22,100.0 | View | |
| Jun 15, 2026 | — | A | A | 22,100.0 | 0.0 | 0.0 | 22,100.0 | View | |
| Jun 15, 2026 | — | A | A | 22,100.0 | 0.0 | 0.0 | 22,100.0 | View | |
| Jun 15, 2026 | — | A | A | 22,100.0 | 0.0 | 0.0 | 22,100.0 | View | |
| Mar 30, 2026 | President, CEO and Secretary | P | A | 28,089.0 | 8.9505 | 251,410.59 | 77,289.0 | View | |
| Mar 30, 2026 | — | P | A | 5,592.0 | 8.9217 | 49,890.15 | 5,592.0 | View | |
| Mar 30, 2026 | Chief Financial Officer | P | A | 7,500.0 | 8.57 | 64,275.0 | 12,886.0 | View |